FIELD: medicine.
SUBSTANCE: BCG strain is cultivated with the prepared culture sonicated. Further antigenic complex representing cytoplasmic and cell membranes is recovered from said sonicated culture. At 15000 rpm, made supernatant fluid (namely the antigenic complex) is mixed with formalin. The reaction mixture is incubated at temperature 37°C in a thermostat, analysed for protein content, and conjugated with polyvinylpyrrolidone (PVP) in mass ratio of protein 1 mg/ml - PVP 600 mg (1:600) in a magnetic stirrer at a room temperature until homogeneous liquid is made.
EFFECT: specific immunomodulatory is capable to restore lost immune responsiveness, to eliminate secondary immunodeficiency, to strengthen protective properties of BCG vaccine.
6 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING SPECIFIC IMMUNOMODULATOR | 2011 |
|
RU2478399C2 |
METHOD FOR ASSESSMENT OF IMMUNOMODULATORS | 2007 |
|
RU2354401C1 |
METHOD FOR OBTAINING A SPECIFIC IMMUNOMODULATOR | 2021 |
|
RU2764467C1 |
METHOD OF SPECIFIC PREVENTION OF TUBERCULOSIS | 2013 |
|
RU2562550C2 |
IMMUNOMODULATING DRUG | 1996 |
|
RU2112543C1 |
METHOD FOR PREVENTING TUBERCULOSIS | 2004 |
|
RU2266753C1 |
VACCINE AGAINST TUBERCULOSIS | 1999 |
|
RU2153354C1 |
RECOMBINANT INFLUENZA VIRUS STRAINS EXPRESSING MYCOBACTERIAL PROTECTIVE ESAT-6 ANTIGEN AND USES THEREOF IN TUBERCULOSIS TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2318872C2 |
METHOD FOR MAKING TUBERCULOUS ANATOXIN | 2008 |
|
RU2360697C1 |
ANTITUBERCULOUS VACCINE | 2007 |
|
RU2443773C2 |
Authors
Dates
2009-09-10—Published
2007-10-25—Filed